Ahmed B. Bayoumy - Publications

NUDT5 variants: implications for thiopurines in gastroenterology.

Journal: The lancet. Gastroenterology & hepatology

Published: March 21, 2026

Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis.

Journal: Journal of Crohn's & colitis

Published: October 10, 2025

Editorial: Dual Advanced Therapy in Refractory Ulcerative Colitis-Hope Beyond Monotherapy.

Journal: Alimentary pharmacology & therapeutics

Published: July 25, 2025

Population Pharmacokinetics Model of Thioguanine in Patients with Inflammatory Bowel Disease.

Journal: Clinical pharmacokinetics

Published: May 15, 2025

Therapeutic Drug Monitoring and Pharmacogenomics of Thiopurines in Inflammatory Bowel Disease: International Guidelines Revisited.

Journal: Therapeutic drug monitoring

Published: March 17, 2025

Acute acoustic trauma requires urgent treatment within 72 h for optimal outcomes: results from the Dutch armed forces.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: February 04, 2025

The fate of thiopurine metabolites after switching to low-dose thiopurine with allopurinol or thioguanine in IBD patients: A retrospective analysis.

Journal: British journal of clinical pharmacology

Published: January 21, 2025

The 'Obesity First' approach: Redefining the future of healthcare.

Journal: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology

Published: December 15, 2024

Comment on: A Soaring Price, a Silent Fight: Thioguanine Portends New Access Barriers to Life-Saving Treatments for Children With Cancer: The Ugly Duck or The Chicken with the Golden Eggs: The Crisis in Thioguanine Accessibility.

Journal: Pediatric blood & cancer

Published: November 13, 2024

DNA-Thioguanine (DNA-TG) Is a Promising Novel Method to Predict Adverse Events to Thiopurine in Inflammatory Bowel Disease.

Journal: Inflammatory bowel diseases

Published: October 24, 2024

The Use of Tissue Concentrations of Biological and Small-Molecule Therapies in Clinical Studies of Inflammatory Bowel Diseases.

Journal: Pharmaceutics

Published: October 17, 2024

Inflammatory Bowel Disease in a Patient Returning from Colombia: Association with Dipeptidyl Peptidase 4 Inhibitor?

Journal: Case reports in gastroenterology

Published: September 21, 2024